CINV

Helsinn Group Announces FDA approval of IV Formulation of Akynzeo for Chemotherapy Induced Nausea and Vomiting
Fri, 04/20/18 - 10:00 am
Helsinn Group
CINV
Akenzeo
Facing off rivals, Merck looks to expand CINV label on positive PhIII Emend study
Fierce Biotech
Mon, 06/29/15 - 10:58 am
Merck
CINV
Emend
chemotherapy-induced nausea and vomiting
AP Pharma's APF530 Poised To Return To FDA Review
Seeking Alpha
Tue, 12/20/11 - 07:50 pm
APF530
AP Pharma
FDA
chemotherapy-induced nausea and vomiting
CINV